These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 4832572

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Relationship between the severity of renal stone disease and urine composition.
    Tiselius HG.
    Eur Urol; 1979; 5(5):323-7. PubMed ID: 446508
    [Abstract] [Full Text] [Related]

  • 23. Renal calculi: pathogenesis, diagnosis, and medical therapy.
    Preminger GM.
    Semin Nephrol; 1992 Mar; 12(2):200-16. PubMed ID: 1561497
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of factors involved in calcium stone formation.
    Abraham PA, Smith CL.
    Miner Electrolyte Metab; 1987 Mar; 13(3):201-8. PubMed ID: 3627051
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Study of inhibitor and nucleator activities in calcium stone formers.
    Duranti E, Imperiali P, Badii M, Capiccioni S, Masi MG, Sasdelli M.
    Proc Eur Dial Transplant Assoc; 1983 Mar; 20():445-9. PubMed ID: 6657667
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effectiveness and mode of action of orthophosphates in patients with calcareous renal calculi.
    Thomas WC.
    Trans Am Clin Climatol Assoc; 1972 Mar; 83():113-24. PubMed ID: 5040108
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Juvenile renal stone disease: a study of urinary promoting and inhibiting factors.
    Baggio B, Gambaro G, Favaro S, Borsatti A, Pavanello L, Siviero B, Zacchello G, Rizzoni GF.
    J Urol; 1983 Dec; 130(6):1133-5. PubMed ID: 6315967
    [Abstract] [Full Text] [Related]

  • 33. [Clinical and laboratory findings in 470 patients with calcilithiasis of the upper urinary tract].
    Kollwitz AA, Kracht H, Brauer R, Löhe E.
    Urol Int; 1969 Dec; 24(4):318-29. PubMed ID: 5407242
    [No Abstract] [Full Text] [Related]

  • 34. Calcium-uric acid nephrolithiasis.
    Coe FL.
    Arch Intern Med; 1978 Jul; 138(7):1090-3. PubMed ID: 666467
    [Abstract] [Full Text] [Related]

  • 35. The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers.
    Coe FL, Moran E, Kavalich AG.
    J Chronic Dis; 1976 Dec; 29(12):793-800. PubMed ID: 1010873
    [No Abstract] [Full Text] [Related]

  • 36. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H, Suzuki F, Yamaguchi K, Nishikawa Y, Kotake T.
    Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
    [Abstract] [Full Text] [Related]

  • 37. The effect of bendroflumethiazide on total, ultrafiltrable and ionized calcium in serum in normocalcaemic renal stone formers and in hyperparathyroidism.
    Jorgensen FS, Transbol I, Binder C.
    Acta Med Scand; 1973 Oct; 194(4):323-6. PubMed ID: 4749171
    [No Abstract] [Full Text] [Related]

  • 38. Are stone formers maladapted to refined carbohydrates?
    Rao PN, Gordon C, Davies D, Blacklock NJ.
    Br J Urol; 1982 Dec; 54(6):575-7. PubMed ID: 6758911
    [No Abstract] [Full Text] [Related]

  • 39. Hypertension in kidney stone patients.
    Cupisti A, Morelli E, Meola M, Cozza V, Parrucci M, Barsotti G.
    Nephron; 1996 Dec; 73(4):569-72. PubMed ID: 8856253
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.